Abstract
Following bone marrow transplantation (BMT) investigations on the recovery of the B and T lymphocyte populations have focused on the peripheral blood and only marginally regard the bone marrow. An immunohistochemical and morphometric study was performed on 352 trephine biopsies derived from 123 patients with chronic myelogenous leukemia (CML) at standardized endpoints before and after allogeneic BMT and compared to a control group. The purpose of this investigation was to quantify the B-CD20+ and T-CD45RO+ lymphocyte subsets and to determine possible relationships with the occurrence of acute and chronic GVHD. Moreover, we studied the dynamics of lymphocyte repopulation in the post-transplant period, correlations with the total peripheral lymphocyte count and differences associated with sibling vs alternate HLA-compatible (unmanipulated) marrow grafts. Morphometric analysis revealed a very fast regeneration of CD45RO+ and CD20+ marrow lymphocytes in the first 2 weeks following BMT. In less than 2 months, in most patients, the post-transplant quantity of lymphocytes was comparable to that of the normal bone marrow. This finding was opposed to the profound depression of the absolute lymphocyte count in the peripheral blood. No relevant relationships could be calculated between engraftment status and the lymphocyte repopulation in the bone marrow. On the other hand, significant correlations were calculable between the development of (chronic and acute) GVHD including severity with the number of CD45RO+ lymphocytes. In non-related graft constellations a more frequent evolution of acute grade III + IV GVHD was detectable. This complication was accompanied by an increased quantity of CD45RO+ lymphocytes in the marrow. Bone Marrow Transplantation (2001) 27, 425–431.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gratwohl A, Hermans J, Niederwieser D et al. Bone marrow transplantantion for chronic myeloid leukemia: long-term results Bone Marrow Transplant 1993 12: 509–516
Appelbaum FR, Clift R, Radich J et al. Bone marrow transplantation for chronic myelogenous leukemia Semin Oncol 1995 22: 405–411
Beelen DW, Graeven U, Elmaagacli AH et al. Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome Blood 1995 36: 2981–2990
Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse Br J Haematol 1997 99: 30–35
Lamparelli T, Van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience Bone Marrow Transplant 1997 20: 1057–1062
Van Rhee F, Szydlo RM, Hermans J et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogeneous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1997 20: 553–560
Clift RA, Anasetti C . Allografting for chronic myeloid leukaemia Baillière's Clin Haematol 1997 10: 319–336
Dini G, Lamparelli T, Rondelli R et al. Unrelated donor marrow transplantation for chronic myelogenous leukaemia Br J Haematol 1998 102: 544–552
Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962–968
Gale RP, Hehlmann R, Zhang MJ et al. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia Blood 1998 91: 1810–1819
Giralt S, Szydlo R, Goldman JM et al. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry Blood 2000 95: 410–415
Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation Bone Marrow Transplant 1990 5: 209–226
Verma UN, Mazumder A . Immune reconstitution following bone marrow transplantation Cancer Immunol Immunother 1993 37: 351–360
Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic marrow transplantation Bone Marrow Transplant 1993 12: 469–475
Ottinger, HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 1996 88: 2775–2779
Storek J, Saxon A . Reconstitution of B-cell immunity following bone marrow transplantation Bone Marrow Transplant 1992 9: 395–408
Ferrara JLM, Degg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667–674
Enright H, Davies SM, DeFor T et al. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host diseases are protective Blood 1996 88: 714–720
Gallardo D, García-López J, Sureda A et al. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase Bone Marrow Tranplant 1997 20: 945–952
Barrett AJ, van Rhee F . Graft-versus-leukaemia Baillière's Clin Haematol 1997 10: 337–355
Atkinson K, Hansen JA, Storb R et al. T-cell subpopulation identified by monoclonal antibodies after human marrow transplantation Blood 1982 59: 1292–1298
Linch DC, Knott LJ, Thomas PM et al. T-cell regeneration after allogeneic and autologous bone marrow transplantation Br J Haematol 1983 53: 441–458
Storek J, Ferrara JL, Ku N et al. B cell reconstitution after bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993 12: 387–398
Storek J, Witherspoon RP, Store R . T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life Bone Marrow Transplant 1995 16: 413–425
Trenschel R, Bernier M, Delforge A et al. Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation Leuk Lymphoma 1998 30: 325–352
Storek J, Witherspoon RP, Webb D, Storb R . Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease Am J Hematol 1996 52: 82–89
Mason DY, Comans-Bitter M, Cordell JL et al. Antibody L26 recognizes an intercellular epitope on the B-cell-associated CD20 antigen Am J Pathol 1990 136: 1215–1222
Norton AJ, Ramsay AD, Smith SH et al. Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues J Clin Pathol 1986 39: 399–405
Thaler J, Greil R Dietze O, Huber H . Immunohistology for quantification of normal bone marrow lymphocyte subsets Br J Haematol 1989 73: 576–577
Falini B, Martelli MF, Tarallo F et al. Immunohistological analysis of human bone marrow trephine biopsies using monoclonal antibodies Br J Haematol 1994 56: 365–386
Knapp W, Rieber P, Dörken B et al. Towards a better definition of human leucocyte surface molecules Immunol Today 1998 10: 253–258
Kaiserling E, Horny HP, Engst U, Walz R . Immunohistology for quantification of normal bone marrow lymphocyte subsets Br J Haematol 1989 72: 576–577
Horny HP, Wehrmann M, Griesser H et al. Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens Am J Clin Pathol 1993 99: 142–149
Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes) J Histochem Cytochem 1984 32: 219–229
Koehne G, Zeller W, Stockschlaeder M, Zander AR . Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1997 19: 149–156
Leitenberg D, Rappeport JM, Smith BR . B-cell precursor bone marrow reconstitution after bone marrow transplantation Am J Clin Pathol 1994 102: 231–236
Thiele J, Kvasnicka HM, Fischer R . Bone marrow histopathology in chronic myelogenous leukemia (CML) – evaluation of distinctive features with clinical impact Histol Histopathol 1999 14: 1241–1256
Holan V, Kohno K, Minowada J . Natural human interferon-alpha augments interleukin-2 production by a direct action on the activated IL-2-producing T-cells J Inter Res 1991 11: 319–325
Gibson FM, Malkovska V, Myint AA et al. Mechanism of suppression of normal hematopoietic activity by lymphokine-activated killer cells and their products Exp Hematol 1991 19: 659–663
Drobyski WR, Ash RC, Casper JT et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia Blood 1994 83: 1980–1987
Svilang L, Pearson ADJ, Green MA et al. Immunopathology of early graft-versus-host disease – a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients Transplantation 1991 52: 1029–1036
Sakamoto H, Michaelson J, Jones WK et al. Lymphocytes with a CD4+ CD8− CD3− phenotype are effectors of experimental cutaneous graft-versus-host disease Proc Natl Acad Sci USA 1991 88: 10890–10894
Sale GE, Anderson P, Browne M, Myerson D . Evidence of cytotoxic T-cell destruction of epidermal cells in human graft-vs-host disease. Immunohistology with monoclonal antibody TIA-1 Arch Pathol Lab Med 1992 116: 622–625
Diamond DJ, Chang KL, Jenkins KA, Forman SJ . Immunohistochemical analysis of T cell phenotypes in patients with graft-versus-host disease following allogeneic bone marrow transplantation Transplantation 1995 59: 1436–1444
Acknowledgements
We are greatly indebted to Mrs B Rosenbach, Mrs M Wonschick and Mrs H Tilemann for their excellent technical assistance. This work was supported by a grant from the Dr M Scheel Foundation for Cancer Research (grant number: 70-2134-Th1).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thiele, J., Kvasnicka, H., Beelen, D. et al. Reconstitution of the CD45RO+ and CD20+ lymphoid marrow population following allogeneic bone marrow transplantation for Ph+ CML. Bone Marrow Transplant 27, 425–431 (2001). https://doi.org/10.1038/sj.bmt.1702789
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702789